Correlation between 18F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1&agr; in transplanted VX2 tumors

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nuclear medicine communications

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MNM.0b013e328364a9e2PMID 23887273
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bioevaluation study of 32P-CP-PLLA particle brachytherapy in a rabbit VX2 lung tumor model.

  2012cited by this paper
• Molecular Mechanism Underlying the Detection of Colorectal Cancer by 18F-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography

  2012cited by this paper
• Dynamic FDG PET for assessing early effects of cerebral hypoxia and resuscitation in new-born pigs

  2012cited by this paper
• Correlation Between 18F-FDG Uptake on PET and Molecular Biology in Metastatic Pulmonary Tumors

  2011cited by this paper
• Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors

  2010cited by this paper
• Carbonic Anhydrase IX Expression Correlates with FDG Uptake by Primary Non–Small Cell Lung Cancer

  2010cited by this paper
• High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer

  2010cited by this paper
• Impact of 18-Fluorodeoxyglucose Positron Emission Tomography on the Management of Pancreatic Cancer

  2010cited by this paper
• Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.

  2010cited by this paper
• HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.

  2010cited by this paper
• Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models.

  2010cited by this paper
• Expression of hypoxia-inducible factor-1 alpha (HIF-1α) in patients with the gallbladder carcinoma

  2010cited by this paper
• F-fluorodeoxyglucose Positron Emission Tomography to Predict Survival in Patients With Operable Esophageal Cancer

  2009cited by this paper
• Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer.

  2009cited by this paper
• Correlations between selected tumor markers and fluorodeoxyglucose maximal standardized uptake values in esophageal cancer.

  2009cited by this paper
• Molecular imaging of cancer—evaluating characters of individual cancer by PET/SPECT imaging

  2009cited by this paper
• 18F-FDG PET Findings and GLUT-1 Expression in IPMNs of the Pancreas

  2008cited by this paper
• Hypoxia, HIF1 and glucose metabolism in the solid tumour

  2008cited by this paper
• FDG uptake, a surrogate of tumour hypoxia?

  2008cited by this paper
• 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II

  2008cited by this paper
• Correlation of GLUT-1 Overexpression, Tumor Size, and Depth of Invasion with 18F-2-fluoro-2-deoxy-d-glucose Uptake by Positron Emission Tomography in Colorectal Cancer

  2006cited by this paper
• Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer.

  2005cited by this paper
• Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.

  2003cited by this paper
• HIF-1 and tumor progression: pathophysiology and therapeutics.

  2002cited by this paper
• Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.

  2001cited by this paper
• Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.

  2001cited by this paper
• The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.

  2000cited by this paper
• Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies.

  2000cited by this paper
• Oncogenic alterations of metabolism.

  1999cited by this paper
• Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

  1999cited by this paper

• Correlation between CT spectral quantitative parameters and expression levels of HIF-1α and ALX1 in non-small cell lung cancer

  2024cites this paper
• The Effect of GLUT1 and HIF-1α Expressions on Glucose Uptake and Patient Survival in Non-Small-Cell Lung Carcinoma

  2023influential citation
• Rabbit VX2 lung tumor models can form early nodal metastases

  2019cites this paper
• Rational design of temperature-sensitive blood-vessel-embolic nanogels for improving hypoxic tumor microenvironment after transcatheter arterial embolization

  2018cites this paper
• Value of combining serum carcinoembryonic antigen and PET/CT in predicting EGFR mutation in non-small cell lung cancer.

  2018influential citation
• Hypoxia in cervical cancer: from biology to imaging

  2017cites this paper
• Comparison of FDG and FLT PET/CT Imaging Based on Human Non-Small Cell Lung Carcinoma Tumor Size in a Small Animal Model

  2016cites this paper
• Identification of novel GLUT inhibitors.

  2016cites this paper
• Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876

  2016cites this paper
• Under hypoxia conditions contactin-1 regulates the migration of Mkn45 cells through the RhoA pathway

  2015cites this paper
• Biomarkers in preclinical cancer imaging

  2015cites this paper
• A Non-Neuronal Cholinergic System Regulates Cellular ATP Levels to Maintain Cell Viability

  2014cites this paper